SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-012661
Filing Date
2023-03-21
Accepted
2023-03-21 06:06:10
Documents
16

Document Format Files

Seq Description Document Type Size
1 8-K brhc10050037_8k.htm DEFA14A 26303
2 EXHIBIT 99.1 brhc10050037_ex99-1.htm EX-99.1 27048
3 brhc10050037_ex99-1slide1.jpg GRAPHIC 124459
4 brhc10050037_ex99-1slide2.jpg GRAPHIC 612643
5 brhc10050037_ex99-1slide3.jpg GRAPHIC 283852
6 brhc10050037_ex99-1slide4.jpg GRAPHIC 214883
7 brhc10050037_ex99-1slide5.jpg GRAPHIC 274567
8 brhc10050037_ex99-1slide6.jpg GRAPHIC 426967
9 brhc10050037_ex99-1slide7.jpg GRAPHIC 223651
10 brhc10050037_ex99-1slide8.jpg GRAPHIC 337016
11 brhc10050037_ex99-1slide9.jpg GRAPHIC 351277
12 brhc10050037_ex99-1slide10.jpg GRAPHIC 165880
13 brhc10050037_ex99-1slide11.jpg GRAPHIC 246766
14 brhc10050037_ex99-1slide12.jpg GRAPHIC 348656
15 brhc10050037_ex99-1slide13.jpg GRAPHIC 250064
16 brhc10050037_ex99-1slide14.jpg GRAPHIC 99850
  Complete submission text file 0001140361-23-012661.txt   5509429
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51173 | Film No.: 23747776
SIC: 2834 Pharmaceutical Preparations